3.13.2019 Neonatal Abstinence Syndrome (NAS) Evaluation
RequiredRequired Question(s)
Required 1.

We would like to know the extent to which the Neonatal Abstinence Syndrome (NAS) WebEx, has met your expectations. For each item below, please choose the answer that best describes your response to the statement. 

 Strongly Agree Agree Disagree Strongly Disagree Not Applicable 
The information from this WebEx will be beneficial to me in my work
Overall, I was satisfied this WebEx
Required 2.
We would like to know the extent to which the Neonatal Abstinence Syndrome (NAS) WebEx has met the outlined objectives. For each objective below, please choose the answer that best describes your response to the statement. 
 Strongly Agree Agree Disagree Strongly Disagree Not Applicable 
The session effectively met the objectives
Objective 1. Participants will examine substance use in Pregnancy and subsequent Neonatal Abstinence Syndrome prevalence
Objective 2. Participants will discuss identification and treatment for substance exposed infants vs. those diagnosed with Neonatal Abstinence Syndrome
Objective 3. Participants will apply what we know (and what we don't yet know) about long-term effects of substance use in utero
Required 3.
We would like to further understand the extent that the Neonatal Abstinence Syndrome (NAS) WebEx met your expectations. For each item below, please choose the answer that best describes your response to the statement. 
 Strongly Agree Agree Disagree Strongly Disagree Not Applicable 
The presenter, Molly McMillion.RN, BSN, IBCIC, LCCE, CPST held my attention
The audiovisuals were helpful
I would recommend this presentation to my colleagues
4.
Please suggest topics for future conferences or WebEx
 

350 characters left.
5.

Please provide any additional comments 


 

350 characters left.
For questions, email Judy Koehler at jkoehler@marshall.edu